Ziprasidone Hydrochloride
Product Images NDC 63187-168

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ziprasidone Hydrochloride (NDC 63187-168). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (0d763aa4 Bc18 430a Baa1 266b6849d534 01)

Chemical structure of the active ingredient ziprasidone hydrochloride, showing its molecular arrangement including a thiophene ring, piperazine ring, chlorinated indole moiety, and carbonyl group.*

FDA Label Image

Ziprasidone 20mg (0d763aa4 Bc18 430a Baa1 266b6849d534 02)

Label for ziprasidone hydrochloride 20mg capsules, containing 30 capsules per bottle. The capsules are described as hard gelatin with an opaque yellow cap and opaque blue body, imprinted with 'SZ 656' in black ink. Manufactured in India by Sandoz Private Limited for Sandoz Inc., Princeton, NJ, and packaged by Proficient Rx LP, Thousand Oaks, CA. Storage instructions specify 20°-25°C (68°-77°F). The label also displays the NDC 63187-168-30 and indicates Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.